Centauri Therapeutics, a UK-based immunotherapy company headquartered in Alderley Park, has raised £6 million in a Series A extension led by the AMR Action Fund, bringing the total Series A financing to £30 million.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?